Fisher Asset Management
PNT

Fisher Asset Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Fisher Asset Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-99,189
Closed -$662K – 1148
2023
Q3 		$662K Hold
99,189
– – ﹤0.01% 811
2023
Q2 		$899K Hold
99,189
– – ﹤0.01% 797
2023
Q1 		$721K Sell
99,189
-19,717
-17% -$146K ﹤0.01% 808
2022
Q4 		$867K Hold
118,906
– – ﹤0.01% 788
2022
Q3 		$919K Buy
+118,906
New +$1.01M ﹤0.01% 688

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Fisher Asset Management's PNT Position: Q4 2023 in Review

Fisher Asset Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 99,189 shares — an estimated $662K sold.

Fisher Asset Management first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $919K in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Fisher Asset Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Fisher Asset Management sold 99,189 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $662K.
  • Fisher Asset Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Fisher Asset Management's POINT Biopharma Global Inc. Common Stock position peaked at $919K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.